Nasal continuous positive airway pressure (CPAP) in moderate to severe cases of obstructive sleep apnea can cause nasal discomfort and other undesirable problems.The aim of our study was to test the effects of sodium hyaluronate on nasal problems that patients experienced in their daily lives, sleepiness, nasal resistance to airflow, nasal mucociliary clearance, changes in inflammatory markers and compliance to CPAP in three groups of patients with obstructive sleep apnea syndrome on CPAP therapy. A total of 102 patients with a confirmed diagnosis of obstructive sleep apnea syndrome were randomized into three treatment groups: (1) hyaluronate plus CPAP, (2) saline solution plus CPAP, and (3) CPAP only-groups. Intranasal hyaluronate showed significant benefits in patients who received CPAP therapy, but future studies over a longer period of time after treatment should be performed to corroborate our findings

Effectiveness of intranasal sodium hyaluronate in mitigating adverse effects of nasal continuous positive airway pressure therapy

I. La Mantia
Primo
Writing – Review & Editing
;
C. Andaloro
Secondo
Methodology
2017-01-01

Abstract

Nasal continuous positive airway pressure (CPAP) in moderate to severe cases of obstructive sleep apnea can cause nasal discomfort and other undesirable problems.The aim of our study was to test the effects of sodium hyaluronate on nasal problems that patients experienced in their daily lives, sleepiness, nasal resistance to airflow, nasal mucociliary clearance, changes in inflammatory markers and compliance to CPAP in three groups of patients with obstructive sleep apnea syndrome on CPAP therapy. A total of 102 patients with a confirmed diagnosis of obstructive sleep apnea syndrome were randomized into three treatment groups: (1) hyaluronate plus CPAP, (2) saline solution plus CPAP, and (3) CPAP only-groups. Intranasal hyaluronate showed significant benefits in patients who received CPAP therapy, but future studies over a longer period of time after treatment should be performed to corroborate our findings
2017
CPAP, sleep apnea, intranasal sodium hyaluronate
File in questo prodotto:
File Dimensione Formato  
Effective of intranasal.pdf

solo gestori archivio

Descrizione: ARTICOLO PRINCIPALE
Tipologia: Versione Editoriale (PDF)
Dimensione 3.7 MB
Formato Adobe PDF
3.7 MB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/322696
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 7
social impact